Network origin in James Ingham first degree
Entity | Entity type | Industry | |
---|---|---|---|
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to James Ingham via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Medical/Nursing Services | Chief Operating Officer Corporate Officer/Principal Founder | |
ProterixBio, Inc.
ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Director/Board Member | |
Serica Technologies, Inc.
Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Director/Board Member | |
Atreaon, Inc.
Atreaon, Inc. Pharmaceuticals: OtherHealth Technology Atreaon, Inc. develops proteins for diseases treatment. It operates as a pharmaceutical company that develops medicines for the treatment of arthritis. The company was founded on December 19, 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Other | Director/Board Member | |
ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Warner Lambert (UK) Ltd.
Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Warner Lambert (UK) Ltd. is a manufacturer and wholesaler of pharmaceuticals and over the counter medicines. The company is based in Eastleigh, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Morningside Group Ltd.
Morningside Group Ltd. Investment ManagersFinance Morningside Group (Morningside Group) is a venture capital and private equity firm founded in 1986 by Lok Chung Chan and Chi Chung Chan. The firm is headquartered in Hong Kong. | Investment Managers | Private Equity Investor | |
The University of Stirling | College/University | Undergraduate Degree | |
Public Health Institute
Public Health Institute Miscellaneous Commercial ServicesCommercial Services Public Health Institute is a non profit organization that promotes research, leadership, and partnerships. It focuses on alcohol, tobacco, drugs and mental health, capacity building, chronic disease prevention, communicable disease prevention, disabilities, environmental health, public health systems, and women, youth, and children's health. The company was founded in 1964 and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Eurobiotech, Inc. | Chief Executive Officer | ||
Advanced Cell Diagnostics, Inc.
Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Masters Pharmaceuticals Ltd.
Masters Pharmaceuticals Ltd. Specialty StoresRetail Trade Masters Pharmaceuticals Ltd. provides global healthcare solutions. It distributes prescription and OTC drugs, medical devices and supplies. The firm offers acetylcysteine, aciclovir, amiloride hcl, amitriptyline, baclofen and budesonide products. It supplies advanced medicines to hospitals, pharmacists, clinics and Governments. The company was founded by Suzad Masters and Zulf Masters in 1984 and is headquartered in Elstree, the United Kingdom. | Specialty Stores | Director/Board Member | |
NUCANA PLC | Biotechnology | Founder Chief Operating Officer Founder Director/Board Member | |
Synchroneuron, Inc.
Synchroneuron, Inc. Pharmaceuticals: MajorHealth Technology Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Major | Director/Board Member | |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Pharmaceuticals: Generic | Director/Board Member | |
Cardiff Business School | College/University | Masters Business Admin | |
Tufts University School of Medicine | College/University | Doctorate Degree | |
Cardiff University School of Medicine | College/University | Doctorate Degree | |
Genethics Ltd. | Founder | ||
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Director/Board Member | |
AMYLYX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Artugen Therapeutics Ltd.
Artugen Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Artugen Therapeutics Ltd. develops precision treatments for infections. The company was founded in 2015 and is headquartered in Concord, MA. | Pharmaceuticals: Generic | Director/Board Member | |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Deepbridge Capital LLP
Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Investment Managers | Consultant / Advisor | |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Biotechnology | Founder Chairman | |
Oncobiopharm Ltd. | Chairman | ||
K-Gen, Inc.
K-Gen, Inc. Miscellaneous Commercial ServicesCommercial Services K-Gen, Inc. is an American biotechnology company. The private company is based in San Francisco. | Miscellaneous Commercial Services | Director/Board Member | |
Apnimed, Inc.
Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Packaged Software | Director/Board Member Founder Director/Board Member Director/Board Member | |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014. | Financial Conglomerates | Director/Board Member | |
Ma Pharmaceuticals, Inc. | Director/Board Member | ||
Sixfold Bioscience, Inc.
Sixfold Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sixfold Bioscience Ltd., Sixfold Bioscience, Inc. operates as a biotechnology company that develops next-generation in vivo delivery systems for RNA therapeutics. The company is based in Walnut, CA. | Miscellaneous Commercial Services | Director/Board Member | |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member |
Statistics
International
United States | 26 |
United Kingdom | 21 |
Ireland | 3 |
Hong Kong | 2 |
Netherlands | 2 |
Sectoral
Health Technology | 30 |
Finance | 5 |
Consumer Services | 5 |
Commercial Services | 4 |
Health Services | 3 |
Operational
Director/Board Member | 37 |
Founder | 10 |
Corporate Officer/Principal | 9 |
Chairman | 8 |
Chief Executive Officer | 6 |
Most connected contacts
Insiders | |
---|---|
Isaac Cheng | 25 |
Christopher Barry Wood | 16 |
Hugh Griffith | 12 |
Ian Abercrombie | 5 |
Tina Flatau | 3 |
Keith Lipman | 2 |
Wilfred Sydney Hanna | 2 |
- Stock Market
- Insiders
- James Ingham
- Company connections